Weiter zum Inhalt
Toggle navigation
English
English
Favoritenliste (
0
)
(Voll)
Kontakt
Mein Konto
Abmeldung
Mein Konto
Suche
Erweiterte Suche bearbeiten
Filter bei nächster Suche beibehalten
collection:"CTG"
topic_facet:"Phase: Phase 2"
Erweiterte Suche
Suchverlauf
Struktursuche
Narrative Service
Drug Overviews
Info Guide
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Cytokines%22&type0%5B%5D=Subject&op0%5B%5D=OR
/vufind/Search/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Cytokines%22&type0%5B%5D=Subject&op0%5B%5D=OR
Search /vufind/Search2/Results?filter%5B%5D=collection%3A%22CTG%22&filter%5B%5D=topic_facet%3A%22Phase%3A+Phase+2%22&join=AND&bool0%5B%5D=AND&lookfor0%5B%5D=%22Cytokines%22&type0%5B%5D=Subject&op0%5B%5D=OR
PubPharm (48)
1
Esmolol in Sepsis Management:Evaluating Immunomodulatory Effects and Impact on Patient Outcomes : Investigating the Immunomodulatory Effects of Esmolol in Sepsis Management and Its Impact on Patient Outcomes
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
2
A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity : A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
3
Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to tx w/ Teclistamab in RRMM : Phase II Trial of Siltuximab for Cytokine Release Syndrome Prophylaxis Prior to Treatment With Teclistamab in Relapsed or Refractory Multiple Myeloma (RRMM)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
4
Anakinra for the Prevention of Cytokine Release Syndrome and Neurotoxicity in Patients With B-Cell Non-Hodgkin Lymphoma Receiving CD19-Targeted CAR-T Cell Therapy : Phase 2 Pilot Study to Evaluate Efficacy and Safety of Anakinra to Prevent CD19-Targeted CAR-T Cell-Related Cytokine Release Syndrome (CRS) and Neurotoxicity in Patients With B Cell Lymphoma (B-NHL)
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
5
A Study of Itacitinib for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy : A Phase 2 Study of Itacitinib, for the Prevention of Cytokine Release Syndrome Induced by Immune Effector Cell Therapy
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
6
Anakinra in Dengue With Hyperinflammation ( AnaDen ) : Anakinra for Dengue Patients With Hyperinflammation - a Randomized Double-blind Placebo-controlled Trial
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
7
MRG-001 as an Immunoregulatory and Regenerative Therapy for ARDS Patients : A Phase IIa, Double-Blind, Randomized, Multi-Center Study Comparing MRG-001 to Placebo in Patients With Acute Respiratory Distress Syndrome
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
8
A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity : A Phase 2 Trial of Anakinra for the Prevention of CAR-T Cell Mediated Neurotoxicity
enthalten in:
ClinicalTrials.gov
| 2024
Wird geladen...
9
Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to CAR-T Cell Therapy : A Phase II Pilot Study to Evaluate the Role of Siltuximab in Treatment of Cytokine Release Syndrome (CRS) and Immune Effector Cell Associated Neurotoxicity (ICANS) Related to Chimeric Antigen Receptor T-Cell Therapy (CAR-T) in Hematological Malignancies
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
10
Ruxolitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation : An Open-Label Phase II Study of JAK Inhibitor Ruxolitinib for the Prophylaxis of Graft-Versus-Host Disease and Cytokine Release Syndrome After T-cell Replete Haploidentical Peripheral Blood Hematopoietic Cell Transplantation
enthalten in:
ClinicalTrials.gov
| 2023
Wird geladen...
1
2
3
4
5
Nächster »
[5]
Filter & Sortierung
Treffer pro Seite
10
20
50
Sortieren
Relevanz
Neueste zuerst
Älteste zuerst
Verfasser
Zeitschriftentitel
Bibliothek
Standort (Printmedien)
Verwandte Substanzen
Verwandte Substanzen werden ermittelt...
Verwandte Erkrankungen/Symptome
Verwandte Erkrankungen/Symptome werden ermittelt...
Verwandte Gene
Verwandte Gene werden ermittelt...
Systematic Reviews
Filter aufheben
Clinical Studies
Patente
Covid-19/SARS-CoV-2
Exclude Systematic Reviews
Exclude Clinical Studies
Exclude Patents
Ihre gewählten Filter
Filter bei nächster Suche beibehalten
Filter aufheben
Thema: Phase: Phase 2
Medienart
48
Aufsätze
48
E-Artikel
48
E-Ressourcen
Zeitschriftentitel
32
ClinicalTrials.gov
16
WHO International Clinical Trials Registry Plat...
Thema
48
610
Phase: Phase 2
48
Study Type: Interventional
23
Cytokine Release Syndrome
18
Syndrome
15
Recruitment Status: Not yet recruiting
12
Recruitment Status: Completed
8
Recruitment Status: Recruiting
7
COVID-19
5
Neurotoxicity Syndromes
5
Recruitment Status: Terminated
5
Recruitment Status: Withdrawn
4
Acute Lung Injury
4
Lymphoma, Non-Hodgkin
4
Respiratory Distress Syndrome, Newborn
3
Lymphoma
2
Dengue
2
Heart Failure
2
Macrophage Activation Syndrome
2
Medical Condition: COVID-19, cytokine release s...
Alle anzeigen ...
weniger ...
Erscheinungszeitraum
42
2020-
6
2010-2019
Erscheinungsjahr(e)
Von:
Bis:
Sprache
48
Englisch
Haven't found what you're looking for?
Wird geladen...